Looking to hire top REI talent? Want more meaningful conversations with clinic execs and embryologists?

There’s one summer meeting that keeps coming up in those conversations: The Midwest Reproductive Symposium International (MRSi).

In this episode of Inside Reproductive Health, we’re joined by three of its organizers; Dr. GG Collins, Dr. Eric Forman, and Dr. Morgan Wilhoite—who share how they’ve used MRSi to build real connections that last.

What you’ll hear in this episode:

• Why MRSI is uniquely valuable for vendors, fellows, and physicians

• The best ways to meet rising REI talent

• How to make your sponsorship dollars work harder for you

• How Fellows are building their networks before graduation

• What makes the MRSi environment ideal for genuine, lasting collaboration

Whether you’re hiring, building partnerships, or just looking to grow your network, this is a conversation you won’t want to miss.

P.S. I don’t get anything from this, but if you want to save 10% on your registration, use my promo code: GJONES9

Everyone wants to grow their third party IVF program, but are we neglecting patient experience in the process?

This week on Inside Reproductive Health, Eloise Drane, 3 time gestational carrier, MBA, and founder of Family Inceptions, shares her honest take on how responsiveness and individualized care have declined, even as demand has stabilized post-2021.

Drawing from 17 years of experience running her own surrogacy agency, Eloise offers a kind but direct update on:

• Why patient experience is harder than ever to deliver (and how to improve it)

• How consolidation impacts intended parents and surrogacy wait times

• The challenges of startups and in-house agency models in IVF networks

• What she’s looking for in a surrogacy agency before considering merging or acquiring

• Why the “same workflows” just won’t cut it for gestational carrier cycles

If your practice or network is looking to scale GC IVF—and actually retain intended parents—this is a must-listen.

What’s your exit strategy?

For single providers and small fertility practice owners, the difference between a multimillion-dollar sale and walking away with nothing often comes down to timing and preparation.

This week on Inside Reproductive Health, I sit down with Bob Goodman, Richard Groberg, and Dr. Brijinder Minhas of MidCap Advisors to discuss:

• The current state of fertility clinic mergers & acquisitions

• Why many fertility MSOs are preparing to sell their networks

• When it’s too late to maximize your practice’s value

• How selling with a competitor could radically increase your exit price

• The biggest risks that lower your practice’s valuation

If you think you might sell your practice in the next 10-15 years, now is the time to start planning. MidCap’s team works with clinic owners to increase their valuation and secure the best possible deal—and they don’t charge fees unless you get paid.

Don’t leave money on the table. Listen now to learn how to secure your financial future.

Genetics is nobody’s baby—or at least this week’s guest seems to think so.

Dr. Mili Thakur, an REI, geneticist, and consultant through Genome Ally, joins us to break down the gaps in genetic testing, the impact on patient care, and why ASRM and others must step up to set industry-wide standards.

Tune in to hear:

• The risks inconsistent genetic testing poses to patients and clinics.

• How the lack of standardization creates unnecessary workflow burdens.

• Why genetic discrepancies hurt patient retention and third-party treatment conversion.

• The missing tools needed to improve third-party IVF programs.

• Dr. Thakur’s call to action for genetics companies to step up and lead the charge.

Who’s adding the most value in IVF today—and who might not be here tomorrow?

This week on Inside Reproductive Health, Dr. Cristina Hickman, founder of Avenue Center for Reproductive Medicine in London, breaks down the fertility field’s evolving landscape. As a PhD embryologist and clinic owner, she shares her perspective on industry leaders, automation, and the shifting role of technology in fertility care.

Tune in to learn:

• Why some clinic networks might be overextending by bringing too many verticals in-house.

• How automation could scale embryologist efficiency to 2,000+ cycles per year.

• The surprising relationship between robotics and AI in embryology.

• Which companies are providing the most value right now--in lab automation, EMR, financial management, and cryo storage and more

• How new intelligence could challenge the current standard of single embryo transfer.

Listen now to hear Dr. Hickman’s take on where the field is headed—and who’s leading the way.

What if 30% of your fertility clinic’s egg retrievals were for egg freezing?

That’s the reality at FertGroup in Brazil, where Dr. Marcus Dantas Martins, Chief Operating Officer, is leading a transformative approach to fertility care. In this episode, Dr. Dantas reveals how Fert Group is leveraging technology and private equity to expand their influence in the rapidly growing Brazilian market.

Join us as Dr. Dantas discusses:

• The Rise of Egg Freezing (And how the trend is reshaping fertility care in Brazil)

• How Private Equity has shaped their rapid expansion

• FertGroup’s Impact on patient outcomes (And its implications in the broader fertility landscape)

• How FertGroup is making egg freezing more accessible across Brazil.

• Why they bought >50% of the embryoscopes in Brazil to make it happen

Tune in to hear more about the future of fertility care in Latin America and how private equity is shaping the industry.

Lynn Mason, CEO of IVI RMA North America, provides an inside look at how dyad leadership—integrating physician leaders with business leaders—drives innovation and collaboration across IVI RMA Global, Boston IVF Trio, and other key partners. She discusses how their in-house EMR system is used for patient triage and emphasizes the importance of collecting the right data.

With Mason, we explore:

• Leveraging vendors beyond cost savings (Making them extensions of the clinic’s operational system for continuity of care)

• Innovative approaches to time-lapse incubation and pharmacy care

• Collaborations in genetics and clinical AI (Who they’re working with and why)

Mason also hints at potential geographic expansions, providing clues to where IVI RMA might be looking to open or acquire more practices.

Are time-lapse incubators a necessity or just a nice-to-have? 

While the clinical improvements may seem incremental, three IVF lab directors—Ms. Christine Yeh, Dr. Mina Alikani, and Prof. Alison Campbell—explain why they are essential for the future of standardized fertility care.

Tune in to hear:

• How EmbryoScope helps scale IVF volumes with small teams.

• Why standardization is crucial for both labs and networks.

• How an IVF system at CARE Fertility saves six months of embryology time per year.

• The role of AI integration in automating embryo assessments.

• Key mistakes to avoid when implementing time-lapse technology.

Listen in to learn how leading labs are leveraging EmbryoScope to drive efficiency, and find out how your clinic may be eligible for a free 120-day trial through Vitrolife.

Are IVF labs safer today than they were a decade ago? They can be, but much of the available safety potential isn’t being fully realized.

In this week’s episode of Inside Reproductive Health, we’re joined by Dr. Eva Schenkman, an IVF lab director and founder of ArtLab, and Dr. Steven Katz, an REI and founder of REI Protect, to discuss risk mitigation and safety in IVF labs.

Here’s what you’ll learn:

• The biggest risks IVF labs face (and cost effective strategies to reduce them)

• The non-negotiables for lab safety (The 3 must-haves)

• How manual tasks in the lab increase the risk for embryologists and practices.

• What younger embryologists are demanding for better safety and support.

• What Dr. Katz and Dr. Schenkman each like about a company called XiltriX

• The top causes of malpractice lawsuits against fertility practices (and how to avoid them)

Listen now to learn how improving IVF lab safety protects patients, investments, and your practice’s future.

There’s a lot for new fertility doctors to cover when they start at a new practice.

In this week’s episode of Inside Reproductive Health, Dr. Christine Mansfield and Dr. Renee Rivas discuss on boarding strategies for new REIs and share actionable advice from both the mentor and mentee perspectives.

Tune into this week’s episode to learn:

Whether you’re a new fellow or a seasoned practice leader, this episode offers key insights for on-boarding success.